Obesity treatment in Israel — get 3 personalized clinic matches

Eligibility for bariatric surgery in Israel requires a Body Mass Index (BMI) over 40. Patients with a BMI between 35 and 40 qualify if they have obesity-related conditions like type 2 diabetes or hypertension. JCI-accredited centers such as Sourasky Medical Center also evaluate candidates based on previous weight loss attempts.

• BMI threshold: Requires 40+ alone or 35+ with specific serious comorbidities.
• Medical comorbidities: Includes sleep apnea, heart disease, high cholesterol, or joint disease.
• Re-entry criteria: BMI over 30 may qualify if previous bariatric surgery failed.
• Mandatory evaluations: Requires clearance from a multidisciplinary team including surgeons and psychologists.

Bookimed Expert Insight: While public criteria are strict, Israel is a leader in robotic bariatrics. Hospitals like Sourasky Medical Center perform over 34,000 operations annually and offer Da Vinci robotic gastric sleeve surgery. Large centers with over 1,500 beds often have more specialized pediatric endocrinologists, such as Dr. Naomi Vayntrub, who treat obesity-related growth and hormonal disorders in younger patients.

Patient Consensus: Patients note that starting dietitian logs at least 6 months early is essential for insurance approval and helps avoid common delays. Many also mention that having heart-related health issues can sometimes speed up the medical clearance process.

Israel officially approves Wegovy, Mounjaro, Saxenda, Razin, and Xenical for chronic weight management. The Ministry of Health regulates these treatments through specific Body Mass Index (BMI) criteria. Patients generally qualify with a BMI of 30 or higher. Those with a BMI of 27 plus comorbidities also qualify.

• Injection therapies: Once-weekly Wegovy (Semaglutide) and Mounjaro (Tirzepatide) target GLP-1 and GIP receptors.
• Daily injectables: Saxenda (Liraglutide) remains a standard option for long-term weight control.
• Oral medications: Razin (Phentermine) acts as an appetite suppressant for long-term therapeutic use.
• Absorption blockers: Xenical (Orlistat) reduces fat absorption and is available in local pharmacies.

Bookimed Expert Insight: Israeli medical centers like Sheba and Sourasky prioritize multidisciplinary care over simple prescriptions. While Sheba covers 1,990 specialties, specialists like Prof. Naomi Vayntrub at Sourasky focus on obesity-linked pathologies. This integrated approach ensures medications are paired with metabolic screening for better long-term results.

Patient Consensus: Patients note that while medications are approved, insurance coverage through health funds varies. Many report paying 800-1,500 NIS monthly out-of-pocket for private prescriptions when initial coverage is denied.

Israeli public health insurance fully covers bariatric surgery for eligible residents through the four national HMOs. Modern obesity medications like Wegovy are generally excluded from the standard public basket. Most patients must purchase these drugs privately or through supplemental insurance plans at reduced rates.

• Surgery eligibility: Residents with BMI over 40 qualify for full procedure coverage.
• Co-morbidities criteria: BMI between 35 and 40 qualifies with hypertension or diabetes.
• Evaluation process: Candidates must pass a dietitian and mental health professional committee.
• Medication coverage: Ozempic is covered only for patients with type 2 diabetes.
• Supplemental benefits: Private HMO tiers like Maccabi Sheli often subsidize 50% of costs.

Bookimed Expert Insight: Israeli medical centers like Sheba and Sourasky handle over 1,500,000 annual patient visits. This high volume supports specialized departments like the Pediatric Endocrinology unit at Ichilov. Professor Naomi Vayntrub at Ichilov focuses specifically on obesity-related endocrine pathologies. Even if public coverage is denied, these JCI-accredited institutions provide advanced surgical techniques like the Da Vinci robotic sleeve.

Patient Consensus: Patients note that public approval is difficult without a BMI near 50 or severe health issues. Many recommend securing supplemental insurance early to cover up to 80% of costs after a public denial.

Israel's leading centers for obesity care include JCI-accredited facilities like Tel Aviv Sourasky Medical Center and Sheba Medical Center. These institutions provide multidisciplinary treatments, including laparoscopic gastric sleeve and bypass surgeries. Patients benefit from comprehensive programs involving endocrinologists, nutritionists, and psychological support for long-term weight management.

• Surgical diversity: Clinics offer gastric sleeve, bypass, gastric balloon, and Da Vinci robotic surgery.
• Pediatric expertise: Schneider Children's Medical Center specializes in adolescent obesity and metabolic growth disorders.
• Expert leadership: Prof. Naomi Vayntrub at Sourasky heads specialized pediatric endocrinology and metabolism departments.
• High-volume centers: Sheba Medical Center treats over 1.5 million patients annually with 97% laparoscopic success.

Bookimed Expert Insight: While public university hospitals like Sourasky or Rambam offer high-level expertise, they often face significant wait times. Data shows that private facilities like Elisha Hospital or Ramat Aviv Medical Center can expedite the process. These private centers often maintain direct partnerships with top university professors. This allows international patients to access elite surgical talent without the scheduling delays typical of the public system.

Patient Consensus: Patients often recommend prioritizing university-affiliated centers to ensure access to comprehensive emergency support. Many note that virtual consultations are essential to navigate the 20% to 50% out-of-pocket costs accurately.